From: The clinical impact of hepatitis C virus infection in Egyptian multiple myeloma patients
Treatment | Number of patients | OS months | ||
---|---|---|---|---|
Range | (Mean ± SD) | Median | ||
VCD | 54 | 1–156 | 28.5 ± 30.5 | 20.3 |
VRD | 10 | 3–63 | 27.5 ± 17.7 | 26.4 |
VTD | 8 | 12–77 | 41.5 ± 23.2 | 44.5 |
Endoxan-Dexa | 9 | 2–20 | 8.13 ± 6.9 | 5.1 |